Objectives: To investigate the association between a Tic Narrow Phenotype (TNP) & Tic/Stereotypic-Movements-Broad-Phenotype (TSMBP) and the following candidate genes: Dopamine transporter (SLC6A3, also referred to as DAT1), D4 receptor (DRD4) and the Nicotinic acetylcholine receptor CHRNA4 gene.
Methods: Participants from the population-based Missouri Twin Study sample (MOTWIN) were selected.
Measures: Parents and twins completed the Missouri Assessment of Genetics Interview for Children (MAGIC) (Todd et al, 2003) that queries present and past existence of all DSM-IV symptoms of psychopathology. Interviewers had college degrees (psychology or related background) and received a 6-week training course for the MAGIC interview. For this study we used the DSM-IV Tic disorder diagnoses, (transient, chronic, motor and vocal), Tourette syndrome (TS), Stereotypic movements, ADHD, OCD, and related diagnoses. Child Behavior Checklist CBCL/4-18 (Achenbach, 1991) was also completed by the parents. Of 1635 total subjects, 67 were assigned to the TNP which included DSM-IV transient (motor or vocal), chronic (motor or vocal), or Tourette Syndrome from the MAGIC-Parent interview; and 511 twins met criteria for TSMBP which included TNP+SM from MAGIC-Parent interview + 2 CBCL items (Nervous movements and Picks skin rated as 1 or 2). The average age of both phenotypes did not differ (approximately 13 ± 3.2 years).
Results: Cases with TNP and TSMBP had significantly higher co-morbidity for ADHD, OCD, Depression, conduct disorder and oppositional defiant disorder than controls (p<.0001 for each comparison). We found a significant association with rs6090384, a SNP (single nucleotide polymorphism) in exon 2 of the CHRNA4 gene on chromosome 20 (odds ratio 5.6, 95% CI=1.4- 22.6) and TSMBP. No additional associations were found between DAT1 or DRD4 for TSMBP; nor were there any genetic associations found with TNP.
Conclusions: These results provide support for a putative role of a CHRNA4 variant in TSMBP. Replication studies are necessary to confirm these findings.